These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29108386)

  • 21. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.
    Nan YL; Hu YL; Liu ZK; Duan FF; Xu Y; Li S; Li T; Chen DF; Zeng XY
    World J Gastroenterol; 2016 Jun; 22(24):5558-67. PubMed ID: 27350734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for heritable predisposition to epigenetic silencing of MLH1.
    Chen H; Taylor NP; Sotamaa KM; Mutch DG; Powell MA; Schmidt AP; Feng S; Hampel HL; de la Chapelle A; Goodfellow PJ
    Int J Cancer; 2007 Apr; 120(8):1684-8. PubMed ID: 17230510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
    Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
    Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of IL-10 polymorphisms in susceptibility to hepatitis B virus-related hepatocellular carcinoma.
    Peng MW; Lu SQ; Liu J; Dong CY
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
    Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
    Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
    Pasic I; Wong KM; Lee JJ; Espin-Garcia O; Brhane Y; Cheng D; Chen Z; Patel D; Brown C; Bucur R; Reisman D; Knox JJ; Xu W; Hung RJ; Liu G; Cleary SP
    Mol Carcinog; 2018 Jan; 57(1):106-113. PubMed ID: 28892201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
    Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
    Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
    Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Yao JG; Zeng Z; Ma Y; Huang XY; Wei ZH; Liu M; Zhang JJ; Xue F; Zhai B; Xia Q
    Hepatology; 2013 Jul; 58(1):171-81. PubMed ID: 23390017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
    Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
    Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.
    Shang L; Ye X; Zhu G; Su H; Su Z; Chen B; Xiao K; Li L; Peng M; Peng T
    Oncotarget; 2017 Sep; 8(44):76816-76831. PubMed ID: 29100351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The single-nucleotide polymorphisms in
    Zhu X; Kong Q; Xie L; Chen Z; Li H; Zhu Z; Huang Y; Lan F; Luo H; Zhan J; Ding H; Lei J; Xiao Q; Fu W; Fan W; Zhang J; Luo H
    Oncotarget; 2018 Mar; 9(17):13222-13230. PubMed ID: 29568352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients.
    Allam MM; Diab KA; Khalil FO; Khalaf FA; Abdel-Samiee M; Sheble N; Eljaky MA; Zayed E; Othman W; Abd-Elkreem M; Abdelsameea E
    Arch Med Sci; 2022; 18(1):62-70. PubMed ID: 35154526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of
    Lin CH; Hsieh MJ; Lee HL; Yang SF; Su SC; Lee WJ; Chou YE
    J Cancer; 2020; 11(6):1641-1647. PubMed ID: 32047570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction to: The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2021 Apr; 13(1):69. PubMed ID: 33794988
    [No Abstract]   [Full Text] [Related]  

  • 40. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.
    Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.